1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MOONLAKE IMMUNOTHERAPEUTICS - ORDINARY SHARES - CLASS A
MoonLake Immunotherapeutics - Ordinary Shares - Class A XNAS: MLTX

MoonLake Immunotherapeutics - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

about

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibit...

Read More
54.98 1.20 (2.23%)
74.98% Gain from 52W Low
459.7K
XNAS Volume

XNAS 22 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
2.7 / 100
Momentum Score
Technically Neutral
51.2 / 100
Analyst Price Target
No estimates available

11

S

3

W

5

O

0

T

SWOT Analysis

MoonLake Immunotherapeutics Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..